Literature DB >> 31155893

Continuous intraoperative nerve monitoring in thyroidectomy using automatic periodic stimulation in 256 at-risk nerves.

N Hamilton1,2, H Morley1, M Haywood1, S Arman1, G Mochloulis1.   

Abstract

INTRODUCTION: Automatic periodic stimulation of the vagal nerve during thyroidectomy provides real-time feedback of recurrent laryngeal nerve function intraoperatively. To assess the validity of this device, the ability of monitoring to predict recurrent laryngeal nerve palsy was determined and the incidence of recurrent laryngeal nerve palsy recorded.
MATERIALS AND METHODS: All thyroidectomies using APS® (Automatic Periodic Stimulation, Medtronic) nerve monitoring were reviewed over a 27-month period. Changes in signal amplitude and latency during thyroidectomy were recorded from saved data. Postoperative fibreoptic laryngoscopy determined the incidence of vocal cord immobility and recovery of nerve function was assessed from follow-up letters.
RESULTS: A total of 256 at-risk nerves were examined (132 hemi- and 62 total thyroidectomies) in cases involving benign and malignant disease. Permanent recurrent laryngeal nerve palsy occurred in six (2.3%) lobectomies and transient recurrent laryngeal nerve palsy occurred in two lobectomies (< 1%). Sensitivity for detecting postoperative vocal cord immobility was 100% and specificity 85% if the end amplitude was 50% below baseline. The positive predictive value when amplitude was 50% below baseline was 18%. The negative predictive value when amplitude was 50% above or equal to baseline was 100%. Intraoperatively, the amplitude was 50% below baseline more frequently in the vocal cord immobility group (t-test, P < 0.015). No vagal nerve complications occurred.
CONCLUSION: Whilst the incidence of recurrent laryngeal nerve palsy is comparable to rates in the literature, the incidence of transient palsy is lower than published averages. APS is able to reliably predict recurrent laryngeal nerve palsy based on end amplitude.

Entities:  

Keywords:  Laryngeal nerve; Thyroid surgery; intraoperative nerve monitoring

Mesh:

Year:  2019        PMID: 31155893      PMCID: PMC6554569          DOI: 10.1308/rcsann.2019.0053

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  10 in total

1.  Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations.

Authors:  J F Moley; T C Lairmore; G M Doherty; L M Brunt; M K DeBenedetti
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

Review 2.  Complications after total thyroidectomy.

Authors:  N Christou; M Mathonnet
Journal:  J Visc Surg       Date:  2013-06-06       Impact factor: 2.043

3.  Exclusive real-time monitoring during recurrent laryngeal nerve dissection in conventional monitored thyroidectomy.

Authors:  Xiao-Li Liu; Che-Wei Wu; Yi-Shen Zhao; Tie Wang; Peng Chen; Jing-Wei Xin; Shi-Jie Li; Da-Qi Zhang; Guang Zhang; Yan-Tao Fu; Li-Na Zhao; Le Zhou; Gianlorenzo Dionigi; Feng-Yu Chiang; Hui Sun
Journal:  Kaohsiung J Med Sci       Date:  2016-03-30       Impact factor: 2.744

4.  Intraoperative electrophysiologic monitoring of the recurrent laryngeal nerve during thyroid and parathyroid surgery: Experience with 1,381 nerves at risk.

Authors:  Gregory W Randolph; Dipti Kamani
Journal:  Laryngoscope       Date:  2016-07-08       Impact factor: 3.325

Review 5.  Continuous intraoperative neural monitoring of the recurrent nerves in thyroid surgery: a quantum leap in technology.

Authors:  Rick Schneider; Gregory W Randolph; Marcin Barczynski; Gianlorenzo Dionigi; Che-Wei Wu; Feng-Yu Chiang; Andreas Machens; Dipti Kamani; Henning Dralle
Journal:  Gland Surg       Date:  2016-12

6.  Continuous Vagal Nerve Monitoring is Dangerous and Should not Routinely be Done During Thyroid Surgery.

Authors:  David J Terris; Katrina Chaung; William S Duke
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

7.  Electrophysiologic nerve stimulation for identifying the recurrent laryngeal nerve in thyroid surgery: review of 70 consecutive thyroid surgeries.

Authors:  A Echeverri; P B Flexon
Journal:  Am Surg       Date:  1998-04       Impact factor: 0.688

Review 8.  Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy.

Authors:  Adolfo Pisanu; Giulia Porceddu; Mauro Podda; Alessandro Cois; Alessandro Uccheddu
Journal:  J Surg Res       Date:  2013-12-25       Impact factor: 2.192

9.  The mechanism of recurrent laryngeal nerve injury during thyroid surgery--the application of intraoperative neuromonitoring.

Authors:  Feng-Yu Chiang; I-Chen Lu; Wen-Rei Kuo; Ka-Wo Lee; Ning-Chia Chang; Che-Wei Wu
Journal:  Surgery       Date:  2008-06       Impact factor: 3.982

10.  Cardiac arrest with vagal stimulation during intraoperative nerve monitoring.

Authors:  Martin Almquist; Mark Thier; Farhad Salem
Journal:  Head Neck       Date:  2016-02-01       Impact factor: 3.147

  10 in total
  4 in total

1.  The learning curve and safety of continuous intraoperative vagus nerve monitoring in thyroid surgery.

Authors:  A Patel; M Ally; V Venkatachalam; M Hearn; G Mochloulis
Journal:  Ann R Coll Surg Engl       Date:  2022-02-08       Impact factor: 1.951

2.  VITOM 4K 3D Exoscope: A Preliminary Experience in Thyroid Surgery.

Authors:  Peter Kullar; Ravina Tanna; Munira Ally; Ananth Vijendren; George Mochloulis
Journal:  Cureus       Date:  2021-01-14

Review 3.  Intraoperative Recurrent Laryngeal Nerve Monitoring During Pediatric Cardiac and Thoracic Surgery: A Mini Review.

Authors:  Claire M Lawlor; Benjamin Zendejas; Christopher Baird; Carlos Munoz-San Julian; Russell W Jennings; Sukgi S Choi
Journal:  Front Pediatr       Date:  2020-11-27       Impact factor: 3.418

4.  Clinical Experience of Use of Percutaneous Continuous Nervemonitoring in Robotic Bilateral Axillo-Breast Thyroid Surgery.

Authors:  Daqi Zhang; Cheng Wang; Tie Wang; Rui Du; Kunlin Li; Mingyu Yang; Gaofeng Xue; Gianlorenzo Dionigi; Hui Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-08       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.